findmyKOL
Clinical trialNCT03860220CompletedPhase 4Interventional

The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin

SponsorHyo-Soo KimEnrollment252DyslipidemiasHypertension
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Kangwon National University Hospital

    Chuncheon, Gangwon-do, South Korea

  • Korea University Ansan Hospital

    Ansan, Gyeonggi-do, South Korea

  • Hallym University Sacred Heart Hospital

    Anyang-si, Gyeonggi-do, South Korea

  • Cha Bundang Medical Center, Cha University

    Seongnam-si, Gyeonggi-do, South Korea

  • Yeungnam University Hospital

    Daegu, South Korea

  • Hallym University Kangnam Sacred Heart Hospital

    Seoul, South Korea

  • Kyung Hee University Hospital at Gangdong

    Seoul, South Korea

  • Severance Hospital, Yonsei University Health System

    Seoul, South Korea

  • Yonsei University Wonju Severance Christian Hospital

    Wŏnju, South Korea

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 Apr 2019
Primary completion
7 Sept 2023
Completion
7 Sept 2023
Last update posted
27 Apr 2026
Registered enrollment
252
Registry id
NCT03860220

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.